Introduction {#Sec1}
============

The Gram-positive bacterium *Staphylococcus aureus* is able to survive as a commensal organism in the anterior nares and on human skin. A third of the human population are nasal carriers and two-thirds are intermittent carriers, forming a large reservoir for potential infection (Peacock et al. [@CR62]). As a pathogen, *S. aureus* is highly adaptable, with an alarming spread of antibiotic resistance. This limits the range of effective therapies able to combat this organism. *S. aureus* is able to cause a wide range of diseases, from minor skin infections to severe systemic disease (such as bacteraemia, septic arthritis and endocarditis). Also, in the hospital environment, *S. aureus* is responsible for many infections associated with surgical wounds and catheters. The ability to inhabit so many niches with such a range of infectious sequelae is due to a large repertoire of virulence determinants.

The human body has many innate defence mechanisms to prevent infection by invading microbes. Physical barriers (human skin and mucosa) prevent pathogens from ingress. The human skin is composed of tightly bound epithelial cells and covered by a highly cross-linked layer of keratin and is therefore normally impenetrable to bacteria (Proksch et al. [@CR66]). Additionally, the skin produces antimicrobial peptides as well as skin fatty acids which are crucial for host defence (Ong et al. [@CR56]; Niyousaba and Ogawa [@CR53]). Several fatty acids have been isolated from human skin, which have strong antimicrobial activity (Miller et al. [@CR49]; Wille and Kydonieus [@CR82]). The antibacterial activity of unsaturated fatty acids has been well known for many years (Kabara et al. [@CR36]; Knapp and Melly [@CR40]; Shin et al. [@CR74]), the most effective antistaphylococcal skin fatty acid being *cis*-6-hexadecanoic acid (C-6-H, sapienic acid, C16:1Δ6) (Takigawa et al. [@CR76]; Wille and Kydonieus [@CR82]). As well as being antibacterial, C-6-H also has the ability to inhibit virulence determinant production and the induction of antibiotic resistance mechanisms (Clarke et al. [@CR16]; Projan et al. [@CR65]; Schlievert et al. [@CR70]; Takigawa et al. [@CR76]; Kenny et al. [@CR39]). In fact, in murine models of *S. aureus* infection, C-6-H has shown to be an effective treatment. Thus, it is important to understand how C-6-H mediates its effects and the response of *S. aureus* to such assault. A surface protein, IsdA, has been shown to be involved in resistance of *S. aureus* to C-6-H by rendering the cells more hydrophilic (Clarke et al. [@CR16]). Also, wall teichoic acids are required to prevent susceptibility to C-6-H (Kohler et al. [@CR42]).

In order to define bacterial components important in resistance to C-6-H and how its effect on virulence determinant expression is mediated, a global study of gene expression and protein profile analysis in response to C-6-H was carried out.

Materials and methods {#Sec2}
=====================

Bacterial strains and culture conditions {#Sec3}
----------------------------------------

Bacterial strains used in this study are listed in Table [1](#Tab1){ref-type="table"} and were grown in iron-limited tryptic soy broth (TSB^−Fe^) (Oxoid), Chelex-100 (Sigma Aldrich), with the addition of 20 µM 2,2′-dipyridyl (Baldassarri et al. [@CR2]). Antibiotics used were erythromycin (5 µg/ml), lincomycin (25 µg/ml) or tetracycline (5 µg/ml) where appropriate. Cultures were grown at 37 °C and inoculated with an overnight culture to an optical density at 600 nm (OD~600~) of 0.05 into TSB^−Fe^, followed by incubation with agitation at 37 °C. Bacterial growth was monitored by measuring the OD~600~.Table 1Strains used in this studyStrainGenotype/markersReferenceSH1000Functional *rsbU* ^*+*^ derivative of 8325-4Horsburgh et al. ([@CR35])NewmanHigh level of clumping factorDuthie and Lorent ([@CR18])JLA371SH1000 *hla*∷*lacZ hla* ^+^ (Ery^R^)Horsburgh et al. ([@CR35])SJF1293*saeS*∷Tn*551* (SH1000) (Ery^R^)Needham et al. ([@CR51])SJF1295*saeR*∷Tn*551* (SH1000) (Ery^R^)Needham et al. ([@CR51])Reynolds CP5Serotype 5 prototype strain (CP5)Karakawa and Vann ([@CR37])Reynolds (CP^−^)Capsule-negative mutant of Reynolds (CP5) (Ery^R^)Watts et al. ([@CR80])KC046*mrgA*∷*lacZ* (pAZ106) (Ery^R^)Cosgrove (unpublished)

Bacterial killing assays {#Sec4}
------------------------

Bacteria were grown to an OD~600~ of approximately 0.6 in TSB^−Fe^. Cells from 10 ml of culture were harvested by centrifugation for 10 min at 5,000×*g* and 4 °C. The cell pellet was washed twice in sterile dH~2~O by resuspension and centrifugation as above. OD~600~ was measured, and cell suspension was adjusted to OD~600~ of 1.0. Cells were incubated at 37 °C with *cis*-6-hexadecanoic acid (C-6-H; Matreya) and cfu determined at intervals by plating onto TSB^−Fe^ agar. For C-6-H pre-exposure experiments, bacteria were grown to an OD~600~ of 0.5 in TSB^−Fe^ and 8 µg/ml C-6-H was added, prior to continued incubation, with shaking, for 2 h by 37 °C. Cells were then harvested, washed and exposed to C-6-H in the killing assay, as above.

Transcriptional analysis {#Sec5}
------------------------

Total RNA was isolated from cultures (OD~600~ of 0.5), prior to, 10 and 60 min after the addition of 10 µg/ml C-6-H. "RNAprotect Bacteria Reagent" (QIAGEN, Hilden, Germany) was added to 8 ml culture and incubated for 5 min, and cells were harvested by centrifugation (5,000×*g* for 10 min at 4 °C) and resuspended in 1 ml RLT buffer (Qiagen) including 10 µg/ml β-mercaptoethanol. Cells were lysed using a Fast Prep shaker (BIO 101 Savant, Haarlem, The Netherlands) for 3× 40 s at a speed of 6.5 units. RNA was isolated using an "RNeasy Mini Kit 250" from QIAGEN. RNA quantity was measured using a NanoDrop 1000 spectrophotometer and the quality checked by analysis with an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). Reverse transcription and fluorescent labelling reactions were performed using 10 µg total RNA, random hexamer primers mix (Invitrogen), SuperScript III™ Reverse Transcriptase (Invitrogen) and incubation for 1 h at 50 °C. The cDNA was labelled with Cy3- and Cy5-dyed d'CTPs (Amersham) according to the manufacturer's instructions (Scienion, Berlin, Germany).

RNA obtained from three independent biological experiments was utilised, and a dye switch experiment was performed to minimise errors based on the differential dye bleaching or incorporation absorption of Cy3 and Cy5 during the RT reaction. The microarray hybridization and washing of the slides were carried out as recommended by the manufacturer (Scienion, Berlin). Microarray hybridization was at 49 °C for 48 h. The microarrays (Scienion) contained the full genome of *S. aureus* N315. Each slide contained PCR products of 2,334 genes in duplicate copies of each open reading frame (ORF) and multiple controls. Slides were scanned using a Genepix 4000B laser scanner (Axon Instruments Inc., Union City, CA, USA), and the individual signal intensity was analysed using Acuity 4.0 software, according to the manufacture's instructions. Briefly, data were normalised to the mean ratio of means of all features, and all experiments were normalised to each other. Standard deviations and mean values of gene expression ratios based on the two spot replicates on each microarray and three different hybridisation experiments were calculated. Significant changes in gene expression were identified by a mean ratio \<0.5 or \>2.0 and a *p* value \<0.05.

Real-time polymerase chain reaction (RT-qPCR) {#Sec6}
---------------------------------------------

RNA was isolated as described for the transcriptional analysis. Two microgram of RNA was reverse-transcribed to cDNA as above. Master mixes were prepared according to the manufacturer's instructions, using oligonucleotides specific for target genes listed in Table [2](#Tab2){ref-type="table"}. SYBR Green (SensiMix*Plus* SYBR, Quantace, London, UK) was used as a fluorescent nucleic acid dye. RT-qPCR was performed in a Mx3000P Real-Time PCR System (Stratagene), and the following temperature profile was used for amplification. The initial denaturation was at 95 °C for 10 min, and templates were amplified by 40 cycles at 95 °C for 30 s and 54 °C for 1 min. A final step, 1 min at 95 °C, 30 s at 54 °C and 30 s 95 °C was used. A dissociation curve was generated to ensure amplification of a single product and absence of primer dimmers (Nolan et al. [@CR54]). Three reference genes (*gyrB*, *yneR* and *ysxC*) were used which showed no significant change in expression on microarrays at all times and under all conditions. For calculation of the relative levels of gene expression, only *gyrB* was used as the endogenous reference gene.Table 2Oligonucleotides used for RT-PCR analysisOligonucleotidesSequence (5′--3′)gyrB_QFATCACAGCATTTGGTACAGGgyrB_QRCGATAGAAGAATGTTAATAACAATGTTysxC_QFGCAGTAAAAGAAGAACAATATCCysxC_QRGGGTTGCTGTGATGTACGasp23_QFAAACAACAAGAACAAAATCAAGAGasp23_QRACCACCTTCAACAGATACACChprT_QFTGTAAGGAATTGGGAGCAChprT_QRACTTCACCAGTTGACTCAGsceD_QFTCGCATCATCATTAGCAGTAGsceD_QRGTGATAAGTAAACCCTTCATAGTCsaeS_QFGTATTGGCATTATACCAGAACTACsaeS_QRGCGAGTTCATTAGCTATATATAAGCsaeR_QFCCAAGGGAACTCGTTTTACGsaeR_QRCATAGGGACTTCGTGACCATlytS_QFAAAGTTGAAAGAAGTGCATACTAAAGAAGlytS_QRTGTACCGACGATAGAACCATGlytR_QFATTAGGAGCTAAGATTCAAAAGATGlytR_QRTTGACTGCTTGTTCAATACGlrgA_QFGCATCAAAACCAGCACACTTlrgA_QRTGATGCAGGCATAGGAATTGlrgB_QFTATTTGGTGTGGCCTTCCTClrgB_QRAAACAGATTGTTGCCGGTTCPhoP_QFTCGGGTATTAGGTTTAGAATTAGGPhoP_QRGGTAATATCATCGTCAATCTCTTCPhoR_QFAATCCGTCCCATTCAAGAAGTTACPhoR_QRAGGCGTCGTGCTAAATCATTGbutA_QFCGTCTGAAGGTATTACTGTGAATGbutA_QRTGAGAAACTCTGCCCAAAGCagrB_QFTCTGACGGTACTTATGTGACagrB_QRCCAGTGCTATTAGTTCCACTGlytM_QFGCTATACATTCGTAGATGCTCAAGlytM_QRCTCGCTGTGTAGTCATTGTTATChla_QFATGATAGAGATTCTTGGAACCChla_QRAATAACTGTAGCGAAGTCTGGkatA_QFACGAGATCCTAGAACAAATATGAGkatA_QRGTATGTGTGAGAACCGAACCclfA_QFAATGATTCAAGTAGCGTTAGTGclfA_QRTTCGTTGTCGTAGTAGTAGCsarA_QFGAGTTGTTATCAATGGTCACTTATGCsarA_QRCAGTTCTTTCATCATGCTCATTACGcidA_QFCTACTACTACAACTAGGAATCATCcidA_QRTTTAGCGTAATTTCGGAAGCmrgA_QFAGTACAATCTAACATACCCACAATTTCTTGmrgA_QRGAGTGCTAATTCAGTTACGACTTTCTTGrsbU_QFGAAATCGTTAAAGGCTTTGGTTATAGrsbU_QRGCTCATTGTGCCATCGTTATGspa_QFGCAAACCATGCAGATGCTAAspa_QRAACGCTGCACCTAAGGCTAA

Preparation of protein extracts {#Sec7}
-------------------------------

For the preparation of extracellular protein extracts, cytoplasmic protein extracts, ionically bound proteins and membrane proteins, bacteria were grown in TSB^−Fe^ (1 l) to exponential phase (OD~600~ of 1.0) and stationary phase (16 h).

Cells were harvested by centrifugation (9,000×*g* for 10 min), and extracellular proteins from the supernatant were precipitated using 100 % w/v fresh TCA (10 % w/v final volume) and incubated on ice for 30 min. Proteins were harvested by centrifugation (9,000×*g* for 5 min), and the pellet was washed 5 times with 100 % v/v acetone and air-dried for 1.5 h. The precipitated proteins were then washed twice with 100 % v/v ethanol, once with 70 % v/v ethanol and finally with 100 % v/v ethanol, prior to air-drying the pellet overnight at room temperature (RT). Proteins were dissolved in urea solution (8 M urea, 2 M thiourea), with incubation at RT for 30 min. In order to remove insoluble proteins, the suspension was centrifuged for 5 min at 20,000×*g*. The protein concentration was determined for each sample and adjusted to 200 µg protein.

For the isolation of the cytoplasmic proteins, harvested cells were broken by FastPrep as above and the suspension then centrifuged at 20,000×*g* for 10 min at 4 °C. The ensuing supernatant was centrifuged at 150,000×*g* for 2 h at 4 °C, using an ultracentrifuge (Optima™ LE-80 K, Beckman, USA). The supernatant was then centrifuged as above, and the cytoplasmic proteins were then precipitated using 10 % w/v TCA and prepared as described above (for supernatant proteins).

Analytical and preparative 2D-PAGE {#Sec8}
----------------------------------

Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) was performed by using the immobilized pH gradient (IPG) technique as described previously (Bernhardt et al. [@CR7]). First, protein samples were separated on linear IPG strips (ImmobilineTM DryStrips, GE Healthcare, Little Chalfont, UK). For extracellular and ionically bound protein samples, strips in the pH range 3--10 were used, and for cytoplasmic protein samples, the pH range 4--7 was used. 2D gels were loaded with 200 µg protein extract, and the resulting gels were fixed with 50 % v/v ethanol and 3 % v/v acetic acid, for 30 min. Afterwards, 2D gels were stained with SYPRO^®^-Ruby and fixed with 10 % v/v methanol and 7 % v/v acetic acid. The stained gels were finally scanned using a Typhoon 9400 Variable Mode Imager (Amersham Biosciences, Freiburg, Germany). For protein identification by matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry (MALDI-TOF-MS), SYPRO stained protein spots were cut from gels using a spot cutter (Proteome Work™) with a picker head of 2 mm and transferred into 96-well microtiter plates. The proteins were digested with trypsin, and subsequent spotting of peptide solutions onto MALDI targets was performed automatically by using an Ettan Spot Handling Workstation (GE Healthcare, Little Chalfont, UK) using a standard protocol as previously described (Eymann et al. [@CR19]). Actual analyses of spotted peptide solutions were performed as previously described (Wolf et al. [@CR83]).

Results and discussion {#Sec9}
======================

Induced resistance of *S. aureus* to C-6-H {#Sec10}
------------------------------------------

To determine whether *S. aureus* responds to C-6-H, the effect of preincubation with a sub-MIC level of the fatty acid on resistance was determined. Firstly, to confirm the bactericidal effect of C-6-H, SH1000 was grown in TSB^−Fe^ to early exponential phase and challenged with 10 or 20 µg/ml C-6-H over 2 h. We observed a rapid decrease in survival rate. At *t* = 40 min, cells treated with 10 µg/ml showed only 1.3 % survival and cells treated with 20 µg/ml C-6-H showed a survival rate of 1 % (Fig. [1](#Fig1){ref-type="fig"}). The untreated control showed over 55 % survival after 120 min. Conversely, those cells previously exposed to subgrowth inhibitory level of C-6-H were much more resistant than naïve cells. After 1 h, 99 % of naïve cells were dead compared with only 12 % of those pretreated (Fig. [2](#Fig2){ref-type="fig"}). This indicates that *S. aureus* responds to C-6-H treatment by the induction of a resistance mechanism. In order to find out the level of C-6-H-induced resistance, additional assays were performed. C-6-H pretreated cells were incubated with 30, 40, 50 and 60 µg/ml C-6-H in the killing assay (Fig. [3](#Fig3){ref-type="fig"}). Pretreated cells showed resistance up to 50 µg/ml C-6-H challenge. Challenge with 50 µg/ml C-6-H killed over 99.9 % of naïve cells after 60 min of incubation, whereas pretreated cells were 80 % killed after this time. However, once 60 µg/ml C-6-H was used the induced resistance threshold was reached. There is no difference in sensitivity to C-6-H between the preincubated and non-preincubated cells (Fig. [3](#Fig3){ref-type="fig"}). Thus, a resistance mechanism is induced in response to C-6-H. *S. aureus* is an extremely adaptable organism able to respond to environmental assault. Chan and Foster ([@CR12]) reported an increase in resistance to acid stress (pH 2), when the cells were pre-exposed to non-lethal pH 4. How cells become more resistant to C-6-H is unknown, but no alteration in solvent partitioning by the cells was seen (data not shown). Cells grown in iron-limited conditions (as here) express *isdA*, which renders them hydrophilic (Clarke et al. [@CR16]). IsdA is a major surface protein and has multiple roles as an adhesin, as a resistance determinant against human innate defences (including C-6-H), and is required for *S. aureus* survival on human skin (Clarke et al. [@CR15], [@CR16]; Clarke and Foster [@CR14]; Clarke [@CR13]).Fig. 1Bactericidal effect of C-6-H on strain SH1000 wt. SH1000 was grown in TSB^−Fe^ until OD~600~ 0.5--0.6. Cells were harvested, washed with dH~2~O and challenged with 0 (*filled circle*), 10 (*filled square*) or 20 (*filled triangle*) µg/ml C-6-H over 2 h. Samples were taken, and cfu was determined over time. Samples were plated in triplicate, and each experiment was repeated twice. *Error bars* indicate the standard error of the meanFig. 2Induced C-6-H resistance of SH1000 by pre-incubation with a sub-MIC of C-6-H. SH1000 was grown in TSB^−Fe^ with or without 10 µg/ml C-6-H until OD~600~ 0.5--0.6. Cells were harvested, washed with dH~2~O and challenged with 0 (*filled circle*), 10 (*filled square*) or 10 with preincubation (*filled diamond*) µg/ml C-6-H over 2 h. Samples were taken, and cfu was determined over time. Samples were plated in triplicate, and each experiment was repeated twice. *Error bars* indicate the standard error of the meanFig. 3Bactericidal effect of C-6-H on cells preincubated with a sub-MIC concentration. SH1000 was grown in TSB^−Fe^ with (*open symbols*) or without (*filled symbols*) 8 µg/ml C-6-H until OD~600~ 0.5--0.6, as described in chapter 2. Cells were harvested, washed with dH~2~O and challenged with 30 (*open square*, *filled square*), 40 (*open triangle*, *filled triangle*), 50 (*open circle*, *filled circle*) or 60 (*open diamond*, *filled diamond*) µg/ml C-6-H. Samples were taken, and cfu was determined over time. Samples were plated in triplicate, and each experiment was repeated twice. *Error bars* indicate the standard error of the mean

Effect of C-6-H on global gene transcription {#Sec11}
--------------------------------------------

In order to determine mechanisms involved in response to C-6-H, including induction of resistance and inhibition of virulence determinant production, transcriptional profiling was carried out. The expression patterns from exponential phase culture of *S. aureus* SH1000 with and without 10 µg/ml C-6-H were compared. Under these conditions, C-6-H has no significant effect on growth rate or yield. Culture samples for analysis were taken 10 min and 60 min after C-6-H addition. After 10-min incubation with C-6-H, 290 genes were decreased and 293 genes were increased in expression level (Table S1). Besides many genes of unknown function and those encoding hypothetical proteins, there were also many genes whose expression was altered by C-6-H which encode ABC transporters, bacterial secretion systems, cell wall metabolism components, DNA replication and repair pathways as well as central metabolic and pathogenicity determinants. After 60-min incubation with C-6-H, 57 genes were reduced and 92 genes were increased in expression level compared with the untreated control (Table S1). These include genes encoding proteins involved in ABC transporter systems, metabolism of coenzymes and prosthetic groups, amino acid synthesis, stress response and many genes involved in virulence of *S. aureus.*

### Effects of C-6-H on purine and pyrimidine biosynthesis {#Sec21}

The greatest decrease in expression after 10-min C-6-H incubation was shown by genes encoding proteins involved in purine and pyrimidine biosynthesis (Table S1). In particular*, pyrR*, *pyrP, pyrB, pyrC, pyrAA, pyrAB*, *pyrF* and *pyrE* of the *de novo* pyrimidine metabolism were significantly down-regulated (spot vol. ratio 0.09 ± 0.04) in the presence of C-6-H compared with the control. This whole operon is regulated by *pyrR* and strongly depends on the presence of pyrimidine nucleotides (Turner et al. [@CR78]; Paulus et al. [@CR60]). Synthesis of pyrimidine is crucial for the cells to divide and therefore cell survival (Turnbough and Switzer [@CR77]). The regulator *pyrR* showed a decrease in expression (spot vol. ratio of 0.06) in the presence of C-6-H (10-min incubation). Interestingly, after 60-min incubation with C-6-H, the operon *pyrR*-*E* (SA1041--SA1048) was highly increased in expression (Table S1). The regulator *pyrR* is increased in expression (spot vol. ratio 19.6), and genes *pyrP*, *pyrB, pyrC* and *pyrAB* were even more (spot vol. ratio 25 ± 5) up-regulated in expression, suggesting that the rapid response (10 min) of *S. aureus* to C-6-H may alter the intracellular pyrimidine pool, thus requiring increased expression of the genes after the initial adaptation period. Interestingly, the response to C-6-H may be specific as Kenny et al. ([@CR39]) reported no effect of linoleic or oleic acid on expression of genes involved in pyrimidine biosynthesis. How C-6-H and other fatty acids effect bacteria and differential responses alludes to fatty acid-specific mechanisms.

Genes that are involved in purine metabolism such as *xprT* (xanthine phosphoribosyltransferase), *guaA* (GMP synthase), *guaB* (inositol-monophosphate dehydrogenase) and *relA(rsh)* (GTP pyrophosphokinase) also showed a strong decrease in expression in the presence of C-6-H after 10-min incubation (spot vol. ratio 0.3 ± 0.2) (Table S1). After 60-min C-6-H incubation, the expression of *xprT, guaA, guaB* but not *relA* was still decreased. Interestingly, RelA as well as enzymes of the purine biosynthetic pathway has been described to be involved in resistance to lysostaphin (Gründling et al. [@CR30]). Further, RelA (Rsh) may be important in the response to C-6-H as it effects the expression of a number of genes, including *cap* (via CodY) (Geiger et al. [@CR22]; Pohl et al. [@CR64]; Srivatsan and Wang [@CR75]; Wolz et al. [@CR84]).

Effects of C-6-H on cellular transport systems {#Sec12}
----------------------------------------------

The microarray data demonstrated that many genes encoding for ABC transporters were effected in expression in the presence of C-6-H. Two genes, *cbiO* (Cobalt import ATP-binding protein Cibo1) and *cibO2* (Cobalt import ATP-binding protein CibO2), which are part of the cobalt transporter, are decreased in expression. After 10-min incubation with C-6-H, microarray data showed a spot vol. ratio of 0.42 and 0.49. Cobalt is an essential cofactor for several enzymes and other components such as vitamin B12 and must be imported into the cell (Kobayashi and Shimizu [@CR41]). Surprisingly, other genes involved in cobalt transport such as *cbiQ* (transmembrane component) and *cbiN* (small membrane-bound component) were not affected in expression by C-6-H. After 60-min incubation with C-6-H, the *cbiO* genes showed no change in expression compared with the control (Table S1).

The expression of three genes, *potA*, *potB* and *potC*, from the *potABCD* operon were down-regulated after 10-min C-6-H incubation with a spot vol. ratio of 0.28 ± 0.05. After 60-min incubation with C-6-H, the expression of genes from the *potABCD* operon showed no change compared with the control. The operon encodes an ABC transporter that transports polyamines such as putrescine and spermidine across the membrane. Polyamines play an important role in cell proliferation and differentiation, as shown in *E. coli* (Kashiwagi et al. [@CR38]).

Interestingly, the genes encoding for a putative monovalent cation/H^+^ antiporter were increased in expression in the presence of C-6-H (spot vol. ratio of 2.1 ± 0.1). SA0578 (putative antiporter subunit A), SA0579 (putative antiporter subunit B), SA0580 (putative antiporter subunit C), SA0581 (putative antiporter subunit D), SA0583 (putative antiporter subunit E) and SA0584 (putative antiporter subunit F) may be part of a Na^+^/H^+^ antiporter which is involved in resistance to high concentrations of K^+^, Li^+^ and Na^+^ ions. Antiporters play an important role in circulating Na^+^ and H^+^ across the cytoplasmic membrane (Padan and Schuldiner [@CR58]) and are also important for the internal pH maintenance. Recently, we reported the bactericidal mechanisms of C-6-H at different concentrations (Cartron et al. [@CR10]). C-6-H has multiple effects on the cell membrane including loss of the ability to maintain intracellular pH.

Compared with the genes that were affected after 10-min incubation, a completely different set was affected (positively as well as negatively) in expression after incubation with C-6-H for 60 min. The array data revealed that the genes *sirA*, *proP*, *fhuA*, *glpF* and SA2339 were increased in expression by C-6-H incubation. Interestingly, the gene SA2339 is highly up-regulated (spot vol. ratio over 11) in expression in the presence of C-6-H. SA2339 is, according to the database (NCBI), a hypothetical protein which shows similarities to an antibiotic transport-associated protein. The *sirA* gene (staphylococcal iron regulator) encodes for a lipoprotein, and the microarray data revealed a spot vol. ratio of 2.9, only after 60-min C-6-H incubation. The *sirA* gene is part of the operon *sirABC*. Heinrichs et al. ([@CR32]) reported that SirA acts as a membrane-associated siderophore-binding protein. The operon is iron regulated, and transcription is controlled by the Fur protein (Heinrichs et al. [@CR32]). Interestingly, the regulatory gene *fur* showed a down-regulation (spot vol. ratio 0.48) after 10-min incubation with C-6-H. The *fur* gene encodes for the ferric uptake regulator which controls cellular iron homoeostasis (Horsburgh et al. [@CR35]).

Furthermore, the gene *fhuA* (ferrichrome transport ATP-binding protein) was increased in expression after 60-min C-6-H incubation (spot vol. ratio 2.4). The *fhuA* gene is part of the *fhu* system which encodes for a ferric hydroxamate uptake system and therefore involved in iron acquisition from hydroxamate siderophore (Sebulsky et al. [@CR71]). Interestingly, none of the other genes that belong to the *fhu* system were affected in expression by C-6-H. The *fhuD2* gene (spot vol. ratio 3.9) showed an increase in expression after 60-min C-6-H treatment. Sebulsky et al. ([@CR72]) reported that *fhuD2* encodes an iron (III)-siderophore-binding protein. After binding a siderophore, the FhuD2--siderophore complex will be recognised by the Fhu system. Iron is one of the most important nutrients for *S. aureus* and is required for various key metabolic processes. Its acquisition is vital for survival. The *sirABC* operon as well as the *fhu* genes is crucial components in the iron acquisition process.

The gene *proP*, which encodes for a proline/betaine transporter homologue (MacMillan et al. [@CR46]), was increased (spot vol. ratio 2.4) in expression in the presence of C-6-H at 60 min only (Table S1). This transporter is important in balancing osmotic differences between *S. aureus* and its environment. The *proP* gene is part of the VraSR regulon, which includes 13 genes in total and is involved in regulation of the cell wall biosynthesis pathway (Kuroda et al. [@CR44]).

Effects of C-6-H on the cell envelope and cell wall synthesis {#Sec13}
-------------------------------------------------------------

The expression of many genes involved in cell envelope biogenesis, including *lytM,dltABD*, *cidA*, *pbp2* and *pbp4*, was altered in response to C-6-H treatment. The peptidoglycan hydrolase LytM (autolysin) plays a role in cell wall turnover as well as cell division (Ramadurai et al. [@CR67]). After 10-min incubation with C-6-H, the expression of *lytM* was decreased (spot vol. ratio 0.48) in expression, whereas after 60-min incubation no change in expression was observed. LytM hydrolyses peptidoglycan, and it has been proposed that it might play a role in the lysis of cells initiated by cell wall-acting antibiotics (Kusser and Ishiguro [@CR45]), suggesting that C-6-H may induce lysis.

Genes of the *dltABCD* operon, which is important for [d]{.smallcaps}-alanylation of wall teichoic acids (WTA) as well as lipoteichoic acids (LTA), showed a strong decrease in expression in the presence of C-6-H after 10-min treatment. After 60-min C-6-H incubation, no change in expression of the *dltABCD* was observed. The *dltA* gene (spot vol. ratio 0.15) encodes a [d]{.smallcaps}-Alanyl carrier protein ligase and activates [d]{.smallcaps}-alanine using ATP. Also, *dltB*, a predicted transmembrane protein, and *dltD*, a membrane protein (Neuhaus and Baddiley [@CR52]), showed a spot vol. ratio of 0.25 ± 0.02. Surprisingly, *dltC* expression showed no effect of C-6-H in the microarray data. Koprivnjak et al. ([@CR43]) reported that the *dltABCD* operon is highly repressed by a rising concentration of monovalent and divalent (Mg^2+^) cations. This group also mentioned that the transcriptional regulation may be partly due to the ArlSR two-component system. (Koprivnjak et al. [@CR43])

Weidenmaier et al. ([@CR81]) reported the role of the *dltABCD* operon in mediating resistance to cationic antimicrobial peptides (CAMP). DltABCD is able to modify negatively charged cell envelope components with positively charged amino acids, to enhance the net positive surface charge of *S. aureus* leading to CAMP resistance (Peschel [@CR63]). The down-regulation (due to C-6-H) of *dltABD* expression may affect surface charge. Kohler et al. ([@CR42]) showed that wall teichoic acids, which play an important role in *S. aureus* surface charge, are crucial for protection of *S. aureus* against human skin fatty acids such as C-6-H. However, the treatment with C-6-H showed a strong decrease in expression of the *dltABCD* operon within the first few minutes but then recovers.

Penicillin-binding proteins 2 and 4 had altered expression (spot vol. ratios of 2.04 and 0.46, respectively) after 10-min incubation with C-6-H. PBP2 is involved in cell wall metabolism and methicillin resistance (Giesbrecht et al. [@CR23]), and PBP4 is mainly involved in secondary cross-linking of the peptidoglycan layer (Henze and Berger-Bachi [@CR33]), further suggesting that the cell wall of *S. aureus* is involved in protection against fatty acids.

The regulator *lytSR*, which encodes for a sensor histidine kinase (LytS) and a response regulator (LytR), was reduced (spot vol. ratio 0.38 ± 0.04) after 10-min C-6-H incubation (Table S1). LytSR is a sensor--regulator system with both positive and negative regulatory effects on murein hydrolase activity and autolysis (Brunskill and Bayles [@CR8]). It is proposed that LytSR is able to sense a decrease in membrane potential and initiates the transcription of *lrgAB* (Patton et al. [@CR59]; Bayles [@CR4]). The *lrgAB* genes are involved in the regulation of murein hydrolase activity and may play a role in autolysin regulation (Groicher et al. [@CR29]; Bayles [@CR3]). Further studies reported that the *cidA* gene encodes for a holing-like membrane protein that is an effector of murein hydrolase activity and cell lysis, whereas *lrgA* encodes an antiholin that is an inhibitor of CidA (Groicher et al. [@CR29]; Rice et al. [@CR68]). Interestingly, the array data showed that the expression of *lrgAB* is highly increased after 10-min incubation with C-6-H (spot vol. ratios of 89 and 20, for *lrgA* and *lrgB*, respectively) (Table S1) even if its regulatory activator (*lytSR*) is inhibited in expression by C-6-H. LrgA and LrgB are involved in regulation of peptidoglycan hydrolase activity by reducing extracellular activity (Groicher et al. [@CR29]; Bayles [@CR3]). Bayles ([@CR4]) suggested that LrgAB together with their antagonist proteins CidAB was involved in the control of bacterial death and lysis during biofilm formation. Interestingly, the expression of *cidA* was decreased after 10-min C-6-H incubation (spot vol. ratio over 4). The *cidA* gene is in an operon with *cidB*. The *cidB* gene showed no change in expression levels in the presence of C-6-H, but *cidA* was decreased in expression and *cidC* was increased in its expression, respectively.

Further, Rice et al. ([@CR68]) showed that a *lytSR* mutation leads to an increase in autolysis rate and a decrease in *lrgAB* expression. These data were confirmed when Sharma-Kuinkel et al. ([@CR73]) reported that a mutation in the *lytS* gene showed a drastic decrease in the expression of *lrgAB* operon. Interestingly, in this study, the expression of *lytSR* showed a decrease in its transcription in the presence of C-6-H and the expression of the *lrgAB* operon was highly increased in its expression, suggesting that there might be an additional so far unknown regulatory system involved in *lrgAB* control.

We have observed that the bactericidal activity of C-6-H occurs via a variety of mechanisms, including loss of proton motive force (PMF) (Cartron et al. [@CR10]), which may lead to an increase in *lytSR* expression.

The biological role of the *lrg* and *cid* operons has been suggested to be in the control of cell death and lysis during biofilm formation, as well as release of genomic DNA to promote intracellular adhesion in biofilm stability (Bayles [@CR4]). The increased *lrgAB* expression and decreased expression of *cidA* may be due to cell wall stress and is a response that may prevent cell death due to metabolic perturbation. In a separate study, Kenny et al. ([@CR39]) observed a decrease of *lrgA* expression in response to linoleic acid, which demonstrates distinct responses to specific unsaturated long-chain fatty acids by *S. aureus*.

Capsule biosynthesis genes (*cap*) showed a significant increase in expression (spot vol. ratio of 2.4--7) (Table S1). The capsule is involved in the pathogenicity of *S. aureus* by preventing phagocytosis and killing by macrophages (O'Riordan and Lee [@CR57]). Thus, it was possible that the capsule may represent a C-6-H resistance mechanism. Strain SH1000 is not highly encapsulated, and so the role of capsule was determined using strain Reynolds. Killing assays using strain Reynolds and corresponding *cap* strains did not show any significant differences in C-6-H susceptibility (data not shown). Kenny et al. ([@CR39]) also observed an increase in *cap* gene expression in response to linoleic acid by strain MRSA252. As the capsule has an antiphagocytic effect, it may be that host-associated stresses (such as C-6-H) lead to its induction as a general response.

Effects of C-6-H on the expression of virulence determinants {#Sec14}
------------------------------------------------------------

Clarke et al. ([@CR16]) have previously reported a decrease in toxin production in response to C-6-H. The microarray data revealed altered expression of many genes involved in pathogenicity. After incubation with C-6-H, virulence-associated genes such as *nuc,hla, hlb*, *rsbU*, *sarZ, sarA, clfA* and two-component regulator *saeRS* were effected in expression (Table S1).

The thermonuclease (*nuc*) is an extracellular protein that degrades double- and single-stranded DNA and RNA. After 10-min incubation with C-6-H, the expression of *nuc* was decreased (spot vol. ratio 0.3), but after 60-min treatment with C-6-H the expression of *nuc* was increased (spot vol. ratio 2.4). The degradation of extracellular DNA plays an important role in host immune evasion to escape from neutrophils extracellular traps (NETs) (Berends et al. [@CR6]).

Besides, the two-component regulator *saeRS* that encodes for a histidine kinase and a response regulator was affected by -6-H (Giraudo et al. [@CR26]). After 10-min incubation with C-6-H, the expression of *saeRS* genes was decreased (spot vol. ratio 0.4). Novick and Jiang ([@CR55]) reported two additional ORFs in the SaeRS system, *saeP* and *saeQ*, which are likely to be important for the function of the operon (Adhikari and Novick [@CR1]; Geiger et al. [@CR21]). The *saeP* gene, but not *saeQ*, was decreased in expression (spot vol. ratio 0.28) after incubation with C-6-H for 10 min.

Previous reports have shown that SaeRS activates the expression of α-haemolysin (*hla*), β-haemolysin (*hlb*), fibronectin-binding protein (*fnbA* and *fnbB*), protein A (*spa*), coagulase (*coa*), thermonuclease (*nuc*), extracellular adherence protein Eap, IgG-binding protein (*sbi*) and extracellular matrix-binding protein Emp (Giraudo et al. [@CR24], [@CR25]; Goerke et al. [@CR27], [@CR28]; Harraghy et al. [@CR31]). Furthermore, it represses the expression of V8 serine protease (*sspA*) and capsular polysaccharide (type 5) (*cap5*). As many of those virulence determinants (e.g. *hla, hlb, fnbA, nuc*) were decreased in expression due to C-6-H, this may be due to the activity of SaeRS (Table S1).

There was differential expression of surface proteins in response to C-6-H. Clumping factor A (*clfA*), a fibrinogen-binding protein, showed a high increase in expression after 10-min C-6-H incubation (spot vol. ratio 6.5). The ClfA protein plays an important role in the adhesion to host cells (McDevitt et al. [@CR47]) and is responsible for clumping in host blood plasma (McDevitt et al. [@CR48]). Kenny et al. ([@CR39]) reported a similar observation, where *clfA* expression is up-regulated. Interestingly, the surface protein-encoding genes *fnbA* and *fnbB* were decreased in expression by C-6-H. FnbA and B are cell surface-associated proteins which mediate the attachment to host cells (e.g. endothelial cells) and can also act during invasion (Peacock et al. [@CR61]; Xu et al. [@CR85]).

As already reported, the *hla* and *hlb* genes were highly decreased in expression after 60-min C-6-H incubation (spot vol. ratio 0.11 ± 0.02). These encode the major toxins α-haemolysin (*hla*) and β-haemolysin (*hlb*), which are membrane-damaging molecules, expressed in post-exponential phase, and are important for spreading into new host tissues (Bhakdi and Tranum-Jensen [@CR9]). The effect of C-6-H on *hla* expression was expected as earlier reports have shown that fatty acids (e.g. glycerol monolaurate (GML) were able to inhibit the expression of virulence determinants in *S. aureus* (Schlievert et al. [@CR70]; Projan et al. [@CR65]). Clarke et al. ([@CR16]) found that C-6-H is able to inhibit the expression of α-haemolysin (*hla*) and protein A (*spa*) at the transcriptional level. Since no change in RNAIII expression (*agr*, the main regulator of virulence factors) has been observed after the exposure to C-6-H or GML, it leads to the suggestion that the effect of C-6-H on the expression of virulence determinants is due to another regulatory system (Projan et al. [@CR65]; Clarke et al. [@CR16]). In contrast, Kenny et al. ([@CR39]) observed that the expression of *hla* and *spa* was up-regulated after exposure of MRSA252 to linoleic or oleic acid.

The expression of *sbi* (IgG-binding protein) was negatively affected by C-6-H (spot vol. ratio 0.09 and 0.18 and after 10- and 60-min incubation, respectively). Sbi has an important role in adherence to host cells during the infective process and acts similarly to protein A (Zhang et al. [@CR86]).

Effects of C-6-H on general intracellular processes {#Sec15}
---------------------------------------------------

Microarray data revealed altered expression of genes involved in carotenoid biosynthesis. The genes *crtN* (squalene desaturase), *crtM* (squalene synthase), *crtQ* (putative glycosyl transferase), *crtP* (4,4′-diaponeurosporene oxidase) and SA2352 (hypothetical protein) were increased in expression after incubation for 10 min with C-6-H (spot vol. ratio 3.7 ± 1.7). It has been reported that there is a direct correlation between carotenoid production and cell membrane fluidity (Chamberlain et al. [@CR11]; Mishra et al. [@CR50]). The carotenoids insert into the membrane and increase its rigidity, which could lead to its stabilization in response to C-6-H. Previous studies reported that long-chain unsaturated fatty acids could lead to an increase in membrane fluidity (Chamberlain et al. [@CR11]). In the presence of the fatty acid C-6-H, the transcriptome data also showed an increase in expression of genes involved in fatty acid biosynthesis (*fabD, fabG, acpP*) after 60-min challenge conditions with C-6-H (spot vol. ratio 2.1 ± 0.1) (Table S1). The synthesis of fatty acids is essential for membrane phospholipid formation and stability, suggesting that *S. aureus* responds to the potential loss of membrane integrity due to C-6-H by increasing the expression of genes involved in fatty acid biosynthesis.

Several genes involved in stress responses were affected in expression by C-6-H incubation. The *katA* gene encodes catalase and is increased in expression only after 10-min incubation with C-6-H (spot vol. ratio 5). It is important for *S. aureus* for neutralisation of H~2~O~2~, survival and nasal colonisation (Cosgrove et al. [@CR17]).

The microarray data revealed that genes of the Clp family (*clpC*, *clpB* and *clpL*) were increased in expression in the presence of C-6-H (spot vol. ratio 2.4, 3.7 and 13.1, respectively). ClpC is a chaperone with ATPase activity, and together with ClpB, it is highly induced during thermal stress with a function to degrade heat-damaged proteins, as well as an important role in biofilm formation (Becker et al. [@CR5]; Frees et al. [@CR20]). ClpB is required for growth at high temperature (Frees et al. [@CR20]). ClpL is also an ATP-dependent proteinase and is important in the thermotolerance of *S. aureus* (Frees et al. [@CR20]).

In response to C-6-H, there is an up-regulation of urease (*ureA*-*G*) expression (60-min incubation, spot vol. ratio 4 ± 2, Table S1). Urease is involved in hydrolysing urea into NH~3~ (ammonia) and CO~2~ (carbon dioxide) as a nitrogen source and acid resistance.

The transcription of *dhoM* (homoserine dehydrogenase), *thrC* (threonine synthetase) and *thrB* (homoserine kinase) was increased after incubation with C-6-H for 10 min (spot vol. ratio 7.5 ± 3.5) and for 60 min (spot vol. ratio 3.1 ± 0.2). All three proteins are important for amino acid synthesis such as serine, glycine or threonine. ThrC catalyses the last reaction of threonine synthesis from asparate.

Real-time PCR (RT-PCR) {#Sec16}
----------------------

The transcriptome data of selected genes were validated using RT-PCR (Table [3](#Tab3){ref-type="table"}), whereas all samples were amplified in triplicate. The focus was on genes involved in virulence and stress response. The RT-PCR analysis showed that *hla* was 20-fold down-regulated after 60-min incubation with C-6-H. For the genes *lrgA, lrgB, katA, sarA*, *sceD, cidA, lytS* and *butA*, RT-PCR data also confirmed the microarray results, verifying the high impact of C-6-H on the expression of those genes. However, not all qRT-PCR data are in correlation with the effect of C-6-H observed in the microarray data. For *spa*, *hprT*, *phoP*, *asp23*, *lytR* and *saeRS*, no effect on expression due to C-6-H was observed (Table [3](#Tab3){ref-type="table"}). This demonstrates that multiple approaches should be undertaken to verify changes in expression using these types of technologies.Table 3Effect of C-6-H on expression of genes determined by qRT-PCRORF N315GeneGene productFold change RT-PCRSpot vol ratio (microarray)10 min60 min10 min60 minCell envelope and cell wall SA0252*IrgA*Holin-like protein LrgA5.000.2789.971.00 SA0253*IrgB*Holin-like protein LrgB4.000.4320.731.00 SA0265*IytM*Peptidoglvcan hydrolase1.003.000.491.00 SA2329*cidA*Holin-like protein CidA0.231.000.221.00Virulence factors and regulators SA0250*lytS*Two-component sensor histidine kinase0.441.000.431.00 SA0251*lytR*Two-component response regulator1.001.000.351.00 SA0573*sarA*Staphylococcal accessory regulator A2.001.002.371.00 SA0660*saeS*Histidine protein kinase1.001.000.441.00 SA0661*saeR*Response regulator1.001.000.411.00 SA0742*clfA*Fibrinogen-binding protein A, clumping factor1.001.006.541.00 SA1007*hla*Alpha-haemolysin0.410.071.000.13 SA1842*agrB*Accessory gene regulator B3.001.001.001.00 SA1872*rsbU*SigmaB regulation protein RsbU1.001.000.491.00Stress response SA1170*katA*Catalase3.001.005.061.00 SA1984*asp23*Alkaline shock protein 23, ASP231.001.007.521.00Butanoate metabolism SAO122*butA*Acetoin reductase5.001.0016.892.72 Transcriptional regulator SA0641*mrzA*HTH-type transcriptional regulator MgrA (NorA)1.001.000.501.00 SA1515*phoR*Alkaline phosphatase synthesis sensor protein1.001.001.001.00 SA1516*phoP*Alkaline phosphatase synthesis transcriptional regulation1.001.003.311.00Purine and/ or pyrimidine metabolism SA0468*hprT*Hypoxanthine-guanine phosphoribosyltransferase homologue1.001.000.291.00Unknown functions and hypothetical proteins SA1898*sceD*Hypothetical protein, similar to SceD precursor1.003.001.003.18Housekeeping genes SA0005*gyrB*DNA gyrase subunit B1.001.001.001.00 SA1186Hypothetical protein, homologue toyneS from B. subtilis1.001.001.001.00 SA1497*ysxC*Ribosome biogenesis GTP-binding protein YsxC1.001.001.001.00

Effect of C-6-H on the *S. aureus* regulatory system *saeRS* {#Sec17}
------------------------------------------------------------

The SaeRS response regulator is a key system that controls the expression of virulence determinants in *S. aureus* and is required for pathogenesis (Giraudo et al. [@CR24], [@CR25]; Goerke et al. [@CR27], [@CR28]; Harraghy et al. [@CR31]). Interestingly, *saeRS* was down-regulated in response to C-6-H as shown by the transcriptome data. Further, many members of its regulon were decreased in expression as well, which suggests that signal transduction by SaeS may be altered as a direct, or indirect, consequence of C-6-H. It has been proposed earlier that fatty acids (such as GML or lauric acid) might affect the cell membrane and therefore disrupt important signalling mechanisms (Schlievert et al. [@CR70]; Holland et al. [@CR34]; Projan et al. [@CR65]; Ruzin and Novick [@CR69]; Vetter and Schlievert [@CR79]). To investigate the role of the SaeRS system in the molecular mechanism of C-6-H, qRT-PCR experiments were performed. The transcription of *hla* in the presence of a sub-MIC of C-6-H using the *saeS* (*saeS*∷Tn*551*) and *saeR* (*saeR*∷Tn*551*) mutant strains in the SH1000 background was measured. In SH1000 wt, the expression of *hla* showed a reduction of over fourfold and 20-fold in the presence of C-6-H for 10 and 60 min, respectively. The *saeS* mutant strain (*saeS*∷Tn*551)* revealed no significant change in *hla* expression in the presence of C-6-H, at 10 or 60 min (Fig. [4](#Fig4){ref-type="fig"}). Similar results were observed using the *saeR* mutant strain (*saeR*∷Tn*551)* which also showed no significant difference in *hla* expression in the presence of C-6-H, suggesting that the two-component system *saeRS* is implicated in the molecular mechanism of C-6-H. The molecular mechanism of C-6-H in virulence determinant inhibition has not as yet been revealed, but an interference of the signal transduction system in *S. aureus* is a possible scenario.Fig. 4Effect of C-6-H on *hla* expression in *saeRS* mutant strains. *S. aureus* SH1000 wt, SH1000 *saeS*∷Tn*551* and SH1000 *saeR*∷Tn*551* were grown in TSB^−Fe^ until OD~600~ 0.5. 8 µg/ml C-6-H was added to the cultures, and cells were incubated for 10 (*striped bars*) or 60 (*filled bars*) min. Total mRNA was isolated, and an qRT-PCR experiment was performed determining *hla* expression. *Red line* shows significant change of at least 0.5-fold. The samples were measured in triplicate, and qRT-PCR experiment was carried out three times

Effect of C-6-H on protein profiles {#Sec18}
-----------------------------------

Transcriptome analysis revealed a pleiotropic effect of C-6-H on gene expression but whether this is translated into significant changes in protein levels and thus activities required a proteomic analysis. The effect of a sub-inhibitory concentration of C-6-H on the extracellular proteins of *S. aureus* SH1000 was determined using the 2D gel technique (Table [4](#Tab4){ref-type="table"}). Table 4Growth phase associated changes in extracellular protein profileORF N315ProteinGene productOD 1.0 versus 16 hSpot IDSA0009SerSSeryl-tRNA synthetase0.65331SA0091Plc1-Phosphatidylinositol phosphodiesterase precurosr2.29563SA0091Plc1-Phosphatidylinositol phosphodiesterase precurosr4.83565SA0091Plc1-Phosphatidylinositol phosphodiesterase precurosr38.19571SA0128SodM (SodA1)Superoxide dismutase1.60698SA0131Pnp (DeoD1)Purine nucleoside phosphorylase1.11654SA0131Pnp (DeoD1)Purine nucleoside phosphorylase0.06187SA0162AldAAldehyde dehydrogenase homologue0.27294SA0182Hypothetical protein, similar to indole-3-pyruvate decarboxylas1.12280SA0265LytMPeptidoglycan hydrolase0.15454SA0265LytMPeptidoglycan hydrolase0.13460SA0309GehGlycerol ester hydrolase2.29170*SA0309GehGlycerol ester hydrolase3.08171*SA0309GehGlycerol ester hydrolase2.84172SA0309GehGlycerol ester hydrolase1.81175SA0309GehGlycerol ester hydrolase4.03177*SA0309GehGlycerol ester hydrolase9.64199*SA0309GehGlycerol ester hydrolase3.28212SA0309GehGlycerol ester hydrolase1.76224*SA0309GehGlycerol ester hydrolase21.07229*SA0309GehGlycerol ester hydrolase5.23272SA0309GehGlycerol ester hydrolase1.81282SA0309GehGlycerol ester hydrolase0.83421SA0309GehGlycerol ester hydrolase2.75433SA0309GehGlycerol ester hydrolase0.57439SA0309GehGlycerol ester hydrolase3.00443SA0309GehGlycerol ester hydrolase1.20451SA0309GehGlycerol ester hydrolase1.90176SA0309GehGlycerol ester hydrolase1.17217SA0309GehGlycerol ester hydrolase3.97221SA0309GehGlycerol ester hydrolase0.68238SA0309GehGlycerol ester hydrolase2.99248SA0309GehGlycerol ester hydrolase1.32259SA0309GehGlycerol ester hydrolase1.97293SA0309GehGlycerol ester hydrolase3.40418*SA0309GehGlycerol ester hydrolase8.89424*SA0309GehGlycerol ester hydrolase5.58435SA0309GehGlycerol ester hydrolase1.15436*SA0366AhpCAlkyl hydroperoxide reductase subunit C3.04712*SA0375GuaBInositol-monophosphate dehydrogenase0.34308SA0376GuaAGMP synthase2.00274SA0382Set6Superantigen-like protein0.03706SA0482Putative ATP: guanido phosphotransferase SA04820.76366SA0486GltXGlutamyl-tRNA synthetase1.21289SA0486GltXGlutamyl-tRNA synthetase0.41302SA0488CysSCysteinyl-tRNA synthetase0.64309*SA0505FusAElongation factor G0.14162*SA0506TufElongation factor Tu0.69371SA0506TufElongation factor Tu0.63396*SA0544Putative haem peroxidase0.21618*SA0587Lipoprotein, streptococcal adhesin PsaA homologue1.63561SA0587Lipoprotein, streptococcal adhesin PsaA homologue0.22610SA0620Secretory antigen SsaA homologue0.28626SA0674Glycerol phosphate lipoteichoic acid synthase0.87336SA0674Glycerol phosphate lipoteichoic acid synthase0.53343SA0674Glycerol phosphate lipoteichoic acid synthase1.15344SA0674Glycerol phosphate lipoteichoic acid synthase0.70346SA0674Glycerol phosphate lipoteichoic acid synthase0.50353SA0686NrdERibonucleotide-diphosphate reductase subunit alpha0.51189SA0719TrxBThioredoxin reductase1.82508SA0727GapGlyceraldehyde-3-phosphate dehydrogenase0.54447SA0728PgkPhosphoglycerate kinase0.57409SA0731EnoPhosphopyruvate hydratase0.55384SA0732ClpPClpP1.07729SA0775Hypothetical protein0.52296SA0787IS1181 transposase0.37242SA0802NADH dehydrogenase-like protein SA08020.94411SA0820GlpQGlycerophosphoryl diester phosphodiesterase2.31569SA0820GlpQGlycerophosphoryl diester phosphodiesterase1.72570SA0823PgiGlucose-6-phosphate isomerase1.10378SA0829Hypothetical protein0.16573SA0831CdrCoenzyme A disulphide reductase2.08349SA0842FabHFabH, 3-oxoacyl-(acyl carrier protein) synthase homologue1.04489SA0843Fab (FabF)3-oxoacyl-synthase0.94362SA0900SspB1Cysteine protease precursor SspB1.72427SA0900SspB1Cysteine protease precursor SspB1.25432SA0900SspB1Cysteine protease precursor SspB2.53468SA0900SspB1Cysteine protease precursor SspB1.51825SA0901SspAV8 protease0.77474SA0901SspAV8 protease1.26478SA0901SspAV8 protease1.30483SA0901SspAV8 protease1.73486SA0901SspAV8 protease0.39507SA0901SspAV8 protease1.47511SA0901SspAV8 protease1.37490SA0904AtlATL autolysin transcription regulator0.28163SA0908Hypothetical protein1.80417SA0908Hypothetical protein1.90419*SA0935PtsIPhosphoenolpyruvate-protein phosphatase0.09244SA0939Hypothetical protein0.12676SA0945PdhCBranched-chain alpha-keto acid dehydrogenase subunit E20.47192*SA0946PdhDDihydrolipoamide dehydrogenase1.04287*SA1007HlaAlpha-haemolysin5.28531*SA1007HlaAlpha-haemolysin2.71536SA1007HlaAlpha-haemolysin5.04539*SA1007HlaAlpha-haemolysin4.60541*SA1007HlaAlpha-haemolysin1.92651SA1036IleSIsoleucyl-tRNA synthetase0.41132SA1098CodYTranscriptional repressor CodY2.87617SA1099RpsB30S ribosomal protein S20.55514SA1100TsfElongation factor Ts2.23459SA1100TsfElongation factor Ts1.58470SA1128RecARecombinase A0.79389SA1150GlnAGlutamine--ammonia ligase1.70323SA1170KatACatalase1.87263*SA1177TktTransketolase0.40197*SA1177TktTransketolase1.31201SA1177TktTransketolase3.11401SA1533AckAAcetate kinase homologue0.40393*SA1184CitB (AcnA)Aconitate hydratase0.23128*SA1216PepFHypothetical protein, similar to oligoendopeptidase33.50215SA1283Pbp2PBP20.57220SA1308RpsA30S ribosomal protein S10.43363SA1336Glucose-6-phosphate 1-dehydrogenase1.50250SA1342Gnd6-Phosphogluconate dehydrogenase2.22391SA1342Gnd6-Phosphogluconate dehydrogenase2.20400SA1359EfpElongation factor P0.40560SA1409DnaKMolecular chaperone DnaK0.69226SA1409DnaKMolecular chaperone DnaK2.15546*SA1499TigTrigger factor0.10231*SA1520PykAPyruvate kinase0.68203SA1529Metal-dependent hydrolase6.88669SA1553FhsFormate-tetrahydrofolate ligase2.57273SA1553FhsFormate-tetrahydrofolate ligase1.16277SA1579LeuSLeucyl-tRNA synthetase2.68143SA1599TalHypothetical protein, similar to transaldolase1.17659SA1609PckAPhosphoenolpyruvate carboxykinase2.05279SA1627SplFSerine protease SplE, putative2.93667SA1627SplFSerine protease SplE, putative7.46660*SA1627SplFSerine protease SplE, putative7.88670SA1628SplDSerine protease SplD4.68666*SA1629SplCSerine protease SplC4.43656SA1629SplCSerine protease SplC1.41657*SA1630SplBSerine protease SplB6.64646*SA1631SplASerine protease SplA4.55642SA1631SplASerine protease SplA2.01647SA1637LukDLeukotoxin, LukD1.22487SA1653TRAPSignal transduction protein TRAP6.36914SA1695AmpSAminopeptidase ampS1.34397SA1709Ferritin0.32910SA1725SspB2Staphopain, cysteine proteinase1.76725*SA1725SspB2Staphopain, cysteine proteinase6.01754*SA1811HlbBeta-haemolsysin1.28505SA1811HlbBeta-haemolsysin1.02509SA1811HlbBeta-haemolsysin0.38515SA1811HlbBeta-haemolsysin5.31519SA1811HlbBeta-haemolsysin2.31520SA1811HlbBeta-haemolsysin0.29522SA1811HlbBeta-haemolsysin0.65574SA1812Uncharacterized leukocidin-like protein 1 precursor1.64499SA1812Uncharacterized leukocidin-like protein 1 precursor2.19500SA1812Uncharacterized leukocidin-like protein 1 precursor1.21502SA1813Uncharacterized leukocidin-like protein 2 precursor0.72494SA182SodA (SodA2)Superoxide dismutase SodA1.53697SA1836GroELChaperonin GroEL0.37267*SA1898Hypothetical protein, similar to SceD precursor0.27552*SA1905AtpDF0F1 ATP synthase subunit beta0.28383SA1915GlyASerine hydroxymethyltransferase1.24364SA1915GlyASerine hydroxymethyltransferase0.90367SA1927FbaAFructose-bisphosphate aldolase0.61530SA1959GlmSGlucosamine-fructose-6-phosphate transferase1.12218SA1984Asp23Alkaline shock protein 231.66827SA2003HysAHyaluronate lyase precursor0.30156*SA2093SsaASecretory antigen precursor SsaA homolog*ue*0.09592SA2093SsaASecretory antigen precursor SsaA homologue0.10593*SA2097Hypothetical protein, similar to secretory antigen precursor SsaA0.24860*SA2204GpmAPhosphoglycerate mutase, pgm homologue3.01583*SA2204GpmAPhosphoglycerate mutase, pgm homolog*ue*1.36585SA2206SbiIgG-binding protein SBI0.29387*SA2208HlgCGamma-haemolysin component C3.73535SA2209HlgBGamma-haemolysin component B2.47497*SA2334MmvaS3-Hydroxy-3-methylglutaryl CoA synthase0.68434SA2336ClpLATP-dependent Clp proteinase chain clpL0.35210SA2356IsaAImmunodominant antigen A0.23616*SA2356IsaAImmunodominant antigen A0.22635*SA2356IsaAImmunodominant antigen A2.08747SA2356IsaAImmunodominant antigen A1.43822SA2356IsaAImmunodominant antigen A0.24908SA2430AurZinc metalloproteinase aureolysin0.21471SA2430AurZinc metalloproteinase aureolysin0.79496SA2437Hypothetical protein, similar to autolysin precursor0.36191SA2437Hypothetical protein, similar to autolysin precursor0.19193*SA2437Hypothetical protein, similar to autolysin precursor0.16195SA2437Hypothetical protein, similar to autolysin precursor0.11200*SA2437Hypothetical protein, similar to autolysin precursor0.88223SA2437Hypothetical protein, similar to autolysin precursor1.11235SA2437Hypothetical protein, similar to autolysin precursor1.15236SA2437Hypothetical protein, similar to autolysin precursor0.10245SA2437Hypothetical protein, similar to autolysin precursor0.78269*SA2437Hypothetical protein, similar to autolysin precursor0.41422*Table of all identified protein spots from the extracellular fraction. Data for proteins with a spot vol. ratio of ≥2 and ≤0.5 are shown. All proteins had a significance level of 0.05 or less (*T* test 5 % cut-off). Proteins highlighted in italics are significantly changed in the two phases of growth

For the 2D gel analysis of extracellular proteins, culture supernatant was treated with 10 % (w/v) fresh TCA to precipitate all extracellular proteins. Figures [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"} show the extracellular protein expression of *S. aureus* in early exponential phase (OD~600~ 1.0) and stationary phase (16 h incubation). In total, 103 different proteins were identified in the extracellular protein fraction. Nine proteins showed an increase in the amount in stationary phase and 13 proteins showed a decrease in level compared with exponential phase (Table [5](#Tab5){ref-type="table"}). As expected, virulence determinants that are involved in host defence evasion as well as invasion and tissue penetration showed an increased level in stationary phase. For example, α-haemolysin (Hla) was over 4.5-fold increased in level in stationary phase. Also, the glycerol ester hydrolase (Geh) main spots were increased ninefold to 21-fold (Table [4](#Tab4){ref-type="table"}). Decreased protein levels in stationary phase were shown by several hypothetical proteins as well as the peptidoglycan hydrolase (LytM), immunodominant antigen A (IsaA) and secretory antigen (SsaA).Fig. 52D gel image false-colour dual-channel of extracellular proteins in exponential phase with and without C-6-H. Merged 2D gel images of *S. aureus* SH1000 extracellular proteins from exponential phase treated with or without 10 µg/ml C-6-H. Control gel shown in *green*, treated samples shown in *red* and equal expression shown in *yellow*. *Spots* were identified via MALDI-TOFFig. 62D gel image false-colour dual-channel of extracellular proteins in stationary phase with and without C-6-H. Merged 2D gel images of *S. aureus* SH1000 extracellular proteins from stationary phase treated with or without 10 µg/ml C-6-H. Control gel shown in *green*, treated samples shown in *red* and equal expression shown in *yellow*. Spots were identified via MALDI-TOFTable 5Growth phase-dependent changes in extracellular protein profileORF N315ProteinGene productOD 1.0 versus 16 hSpot IDSA0265LytMPeptidoglycan hydrolase0.15454SA0265LytMPeptidoglycan hydrolase0.13460SA0309GehGlycerol ester hydrolase3.08171SA0309GehGlycerol ester hydrolase9.64199SA0309GehGlycerol ester hydrolase21.07229SA0309GehGlycerol ester hydrolase8.89424SA0375GuaBInositol-monophosphate dehydrogenase0.34308SA0393Set15Superantigen-like protein0.12676SA0505FusAElongation factor G0.14162SA0544Putative haem peroxidase0.21618SA0935PtsIPhosphoenolpyruvate-protein phosphatase0.09244SA0945PdhCBranched-chain alpha-keto acid dehydrogenase subunit E20.47192SA1007HlaAlpha-haemolysin5.28531SA1007HlaAlpha-haemolysin4.60541SA1177TktTransketolase0.40197SA1499TigTrigger factor0.10231SA1627SplFSerine protease SplE, putative7.88670SA1628SplDSerine protease SplD4.68666SA1630SplBSerine protease SplB6.64646SA1725Staphopain, cysteine proteinase6.01754SA1898Hypothetical protein, similar to SceD precursor0.27552SA2093SsaASecretory antigen precursor SsaA homologue0.09592SA2093SsaASecretory antigen precursor SsaA homologue0.10593SA2204GpmAPhosphoglycerate mutase, pgm homologue3.01583SA2208HlgCGamma-haemolysin component C3.73535SA2209HlgBGamma-haemolysin component B2.47497SA2356IsaAImmunodominant antigen A0.22635SA2437Hypothetical protein, similar to autolysin precursor0.16195SA2437Hypothetical protein, similar to autolysin precursor0.41422Comparison of the pattern of extracellular protein expression in exponential phase (OD~600~ 1.0) and stationary phase of *S. aureus*. Data for proteins with a spot vol. ratio of ≥2 and ≤0.5 are shown. All genes had a significance level of 0.05 or less (*T* test 5 % cut-off)

In early exponential phase (OD~600~ 1.0), the levels of 15 proteins were altered (≥twofold) in the presence of C-6-H (Table [6](#Tab6){ref-type="table"}). Thirteen proteins showed a reduced level and 2 proteins showed an increased level in the presence of C-6-H. In stationary phase (16 h), 18 proteins showed an altered level of expression in the presence of C-6-H. Thirteen proteins were reduced and 5 were increased in level (Table [6](#Tab6){ref-type="table"}). In the presence of C-6-H, several virulence determinants were reduced in level in exponential phase. The β-haemolysin (Hlb) and γ-haemolysin (HlgC) showed fivefold and 2.5-fold reduction in exponential phase. At stationary phase, Hlb showed no alteration due to C-6-H, but HlgC and HlgB were 3.5-fold reduced. The addition of C-6-H surprisingly showed no apparent effect on Hla level at either growth phase. The lipase (Geh) showed a growth phase-dependent response to C-6-H as it was reduced in exponential phase but induced in stationary phase (Table [5](#Tab5){ref-type="table"}).Table 6Effect of C-6-H on extracellular protein profileORF N315ProteinGene productExpression C6HOD 1.016 hSpot ID (OD 1.0)Spot ID (16 h)SA0131Pnp (deoD1)Purine nucleoside phosphorylase--0.33654SA0265LytMPeptidoglycan hydrolase2.08--454SA0309GehGlycerol ester hydrolase0.23--421SA0309GehGlycerol ester hydrolase--7.38212SA0366AhpCAlkyl hydroperoxide reductase subunit C--0.18712SA0505FusAElongation factor G0.20--162SA0506TufElongation factor Tu0.17--371SA0820GlpQGlycerophosphoryl diester phosphodiesterase--2.88569SA0843Fab (fabF)3-Oxoacyl-synthase0.10--362SA0900SspB1Cysteine protease precursor SspB--7.57427SA0900SspB1Cysteine protease precursor SspB--5.78432SA0901SspAV8 protease--13.24478SA0901SspAV8 protease--9.44483SA0901SspAV8 protease--5.19490SA0935PtsIPhosphoenolpyruvate-protein phosphatase0.18--244SA1100TsfElongation factor Ts0.47--470SA1177TktTransketolase0.25--201SA1184CitB (acnA)Aconitate hydratase0.13--128SA1409DnakMolecular chaperone DnaK0.19--226SA1627SplFSerine protease SplE, putative--0.36670SA1630SplBSerine protease SplB--0.29646SA1631SplASerine protease SplA--0.27642SA1631SplASerine protease SplA--0.13647SA1637LukDLeukotoxin, LukD--0.17487SA1671Hypothetical protein--0.17698SA1725SspB2Staphopain, cysteine proteinase--0.19754SA1811HlbBeta-hemolsysin0.17--505SA1811HlbBeta-hemolsysin0.19--509SA1811HlbBeta-hemolsysin0.16--519SA1812Hypothetical protein--0.44500SA1813Hypothetical protein--0.07494SA1959GlmSGlucosamine-fructose-6-phosphate transferase0.05--218SA2093SsaASecretory antigen precursor SsaA homologue4.74--592SA2093SsaASecretory antigen precursor SsaA homologue6.24--593SA2204GpmAPhosphoglycerate mutase, pgm homologue0.08--585SA2208HlgCGamma-haemolysin component C0.38--535SA2208HlgCGamma-haemolysin component C--0.33535SA2209HlgBGamma-haemolysin component B--0.22497SA2356IsaAImmunodominant antigen A--0.28616SA2356IsaAImmunodominant antigen A--0.21635SA2356IsaAImmunodominant antigen A--0.16747SA2437Hypothetical protein, similar to autolysin--0.43223SA2437Hypothetical protein, similar to autolysin--2.38236Comparison of extracellular protein production in exponential phase (OD~600~ 1.0) and stationary phase in the presence of sub-MIC C-6-H. Data for proteins with a spot vol. ratio of ≥2 and ≤0.5 are shown. All proteins had a significance level of 0.05 or less (*T* test 5 % cut-off)

One hundred and sixty-six cytoplasmic soluble proteins were identified in total and analysed by MALDI-TOF mass spectrometry. The differences in protein expression of exponential and stationary phase cell growth are shown in Table [7](#Tab7){ref-type="table"}, and the effects of C-6-H are shown in Table [8](#Tab8){ref-type="table"} and Figs. [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}. The cytoplasmic proteins of *S. aureus* in early exponential phase (OD~600~ 1.0) and stationary phase (16 h incubation) were compared. Twenty proteins show an increase and 22 a decrease in level in stationary phase (Table [7](#Tab7){ref-type="table"}), with a variety of predicted roles.Table 7Growth phase-dependent changes in cytoplasmic protein profileORF N315ProteinGene productOD 1.0 versus 16 hSA0149CapFCapsular polysaccharide synthesis enzyme Cap5F2.18SA0218MBFormate acetyltransferase3.20SA0224Hypothetical protein, similar to 3-hydroxyacyl-CoA dehydrogenase28.28SA0372Hypothetical protein4.24SA0506TufElongation factor Tu0.28SA0506TufElongation factor Tu0.10SA0513Hypothetical protein0.35SA0564ArgSArginyl-tRNA synthetase0.50SA0707Hypothetical protein3.06SA0730PgmPhosphoglyceromutase0.30SA0755Organic hydroperoxide resistance protein-like2.34SA0774Hypothetical protein0.34SA0793DltA[d]{.smallcaps}-alanine-poly(phosphoribitol) ligase subunit 10.40SA0842FabHFabH, 3-oxoacyl-(acyl carrier protein) synthase homologue0.40SA0843Fab3-oxoacyl-synthase0.44SA0869FabIEnoyl-(acyl carrier protein) reductase0.35SA0959GTP-binding elongation factor homologue0.32SA1019Hypothetical protein2.19SA1045PyrAACarbamoyl phosphate synthase small subunit0.39SA1073FabDMalonyl CoA-acyl carrier protein transacylase0.48SA1096ClpQATP-dependent protease peptidase subunit2.46SA1115RibCRiboflavin kinase/FAD synthase ribC0.17SA1224ABC transporter (ATP-binding protein) homologue0.30SA1224ABC transporter (ATP-binding protein) homologue0.36SA1307EngAGTP-binding protein engA0.34SA1309CmkCytidylate kinase0.36SA1343Hypothetical protein, similar to tripeptidase7.03SA1410GrpEHeat shock protein GrpE0.46SA1456AspSAspartyl-tRNA synthetase0.49SA1456AspSAspartyl-tRNA synthetase0.41SA1522AccAAcetyl-CoA carboxylase carboxyltransferase subunit alpha0.45SA1553FhsFormate-tetrahydrofolate ligase2.77SA1553FhsFormate-tetrahydrofolate ligase2.13SA1609PckAPhosphoenolpyruvate carboxykinase6.03SA1609PckAPhosphoenolpyruvate carboxykinase3.67SA1609PckAPhosphoenolpyruvate carboxykinase6.65SA1692Hypothetical protein2.37SA1709Ferritin4.20SA1724PurBAdenylosuccinate lyase2.12SA1840Hypothetical protein2.02SA1929PyrGCTP synthase0.43SA1936LuxSS-ribosylhomocysteinase0.39SA1984Asp23Alkaline shock protein 2313.54SA1984Asp23Alkaline shock protein 2310.13SA1984Asp23Alkaline shock protein 238.04SA2098Putative 2-hydroxyacid dehydrogenase SA20982.25SA2125Formimidoylglutamase2.12SA2240Hypothetical protein, similar to para-nitrobenzyl esterase chain A8.60SA2317Hypothetical protein0.44SA2336ClpLATP-dependent Clp proteinase chain clpL2.57Comparison of the pattern of cytoplasmic protein expression in exponential phase (OD~600~ 1.0) and stationary phase of *S. aureus*. Proteins with a spot vol. ratio of ≥2 and ≤0.5 are shown. All proteins had a significant level of 0.05 or less (*T* test 5 % cut-off)Table 8Effect of C-6-H on cytoplasmic protein profileORF N315ProteinGene productExpression C6HOD~600~ 1.016 hSA0165Hypothetical protein, similar to alpha-helical coiled-coil--0.15SA0367NADPH-dependent oxidoreductase--2.13SA0419MetBCystathionine gamma-synthase2.11--SA0506TufElongation factor Tu2.31--SA0506TufElongation factor Tu--2.46SA0513Hypothetical protein0.48--SA0707Hypothetical protein0.44--SA0758Hypothetical protein, similar to thioredoxin0.50--SA0869FabIEnoyl-(acyl carrier protein) reductase0.40--SA0884Lipoate-protein ligase homologue--2.09SA1045PyrAACarbamoyl phosphate synthase small subunit0.35--SA1112InfBTranslation initiation factor IF-2--3.52SA1115RibCRiboflavin kinase/FAD synthase ribC0.21--SA1258Hypothetical protein0.10--SA1522AccAAcetyl-CoA carboxylase carboxyltransferase subunit alpha0.35--SA1868Hypothetical protein0.23--SA1943Hypothetical protein0.19--SA1959GlmSGlucosamine-fructose-6-phosphate aminotransferase--2.15SA1959GlmSGlucosamine-fructose-6-phosphate aminotransferase--2.95SA1959GlmSGlucosamine-fructose-6-phosphate aminotransferase2.15--SA1984Asp23Alkaline shock protein 23--0.37SA2084UreCUrease subunit alpha14.42--SA2085UreEUrease accessory protein UreE5.85--SA2085UreEUrease accessory protein UreE--3.28SA2098Putative 2-hydroxyacid dehydrogenase SA2098--2.09SA2311Putative NAD(P)H nitroreductase SA2311--2.62SA2312Ddh[d]{.smallcaps}-lactate dehydrogenase2.44--SA2336ClpLATP-dependent Clp proteinase chain clpL--2.26SA2336ClpLATP-dependent Clp proteinase chain clpL--2.62SA2400Mqo2Malate: quinone oxidoreductase0.44--SA2400Mqo2Malate: quinone oxidoreductase0.27--Comparison of cytoplasmic protein expression in exponential phase (OD~600~ 1.0) and stationary phase in the presence of sub-MIC C-6-H. Data for proteins with a spot vol. ratio of ≥2 and ≤0.5 are shown. All proteins had a significance level of 0.05 or less (*T* test 5 % cut-off)Fig. 7Comparison of the cytoplasmic protein pattern of *S. aureus* SH1000, with or without C-6-H, in exponential phase. Original staining and false-colour dual-channel images of 2D gels of cytoplasmic proteins without C-6-H (*green*) and with C-6-H (*red*). Proteins (200 µg) were isolated from the supernatant of SH1000 or grown in TSB^−Fe^ medium to OD~600~ 0.5, C-6-H was then added, and cultures were further incubated until OD~600~ 1.0. *Yellow* protein spots represent equal amounts in both cultures, the *green* protein spots represent higher amounts in the culture without C-6-H, and protein spots that are *red* are present in higher amounts in the presence of C-6-HFig. 8Comparison of the cytoplasmic protein pattern of *S. aureus* SH1000, with or without C-6-H, in stationary phase. Original staining and false-colour dual-channel images of 2D gels of cytoplasmic proteins without C-6-H (*green*) and with C-6-H (*red*). Proteins (200 µg) were isolated from the supernatant of SH1000 grown in TSB^−Fe^ medium to OD~600~ 0.5, C-6-H was then added, and cultures were further incubated for 16 h (stationary phase). *Yellow* protein spots represent equal amounts in both cultures, the *green* protein spots represent higher amounts in the culture without C-6-H, and protein spots that are *red* are present in higher amounts in the presence of C-6-H

In early exponential phase, the expression levels of 17 proteins were altered (≥2-fold) in the presence of C-6-H (Table [8](#Tab8){ref-type="table"}). Eleven proteins showed a decrease and 6 an increase in level due to C-6-H. In stationary phase, 9 proteins were increased and 2 reduced in the presence of C-6-H. The greatest induction by C-6-H was seen for UreC in exponential phase (14-fold). Also, UreE showed a fivefold induction in protein level (Table [8](#Tab8){ref-type="table"}). The increased urease level is in accordance with the array data (Table S1). A variety of other metabolic proteins were also affected by C-6-H, which alludes to a generalised effect of the inhibitor on cellular processes.

Conclusions {#Sec19}
===========

There was broad (but not exact) correlation between the effects of C-6-H on gene expression and protein level revealing a pleiotropic alteration in cellular physiology and virulence. Despite multiple changes in gene expression as a result of C-6-H exposure, no single resistance mechanism could be identified, which might suggest the contribution of several factors. Our data, however, support the hypothesis that the key regulator of virulence determinant production, SaeR, is affected by C-6-H and results in the reduced expression of several toxins. This would make sense as skin fatty acids are key markers for an environment in which *S. aureus* will colonise as part of the commensal flora. Expression of components able to disrupt the host will destroy this niche and potentiate other defences, thus placing the organism at risk.
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